EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Inspire Medical Systems's Enterprise Value is $1,031.1 Mil.
Inspire Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $96.7 Mil. Therefore, Inspire Medical Systems's EV-to-FCF for today is 10.66.
The historical rank and industry rank for Inspire Medical Systems's EV-to-FCF or its related term are showing as below:
INSP'
s EV-to-FCF Range Over the Past 10 Years
Min: -642.81 Med: -41.58 Max: 5860.07
Current: 10.66
During the past 11 years, the highest EV-to-FCF of Inspire Medical Systems was 5860.07. The lowest was -642.81. And the median was -41.58.
INSP's EV-to-FCF is ranked better than 80.38% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 22.895
vs INSP: 10.66
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inspire Medical Systems (NYSE:INSP) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inspire Medical Systems's PE Ratio (TTM) for today is calculated as:
Inspire Medical Systems's share price for today is $44.61.
Inspire Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.490.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Inspire Medical Systems's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's EV-to-FCF falls into.
Inspire Medical Systems's current Enterprise Value is $1,031.1 Mil.
Inspire Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $96.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire Medical Systems (INSP) has a EV-to-FCF of 10.66 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #82 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 19.6%.
Is Inspire Medical Systems' EV-to-FCF too high?
Inspire Medical Systems' current EV-to-FCF is 10.66. The Medical Devices & Instruments industry median EV-to-FCF is 22.90. Inspire Medical Systems' value of 10.66 is 53.4% below this industry median. Based on the distribution chart, Inspire Medical Systems ranks #82 out of 418 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' EV-to-FCF compare to ENOV and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #82 out of 418 companies for EV-to-FCF. This places Inspire Medical Systems in the top 20% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.90. Inspire Medical Systems' value of 10.66 is 53.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.90, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspire Medical Systems's current EV-to-FCF of 10.66 is 53.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Inspire Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current EV-to-FCF is 10.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (INSP) is currently considered Possible Value Trap. The stock's GF Value™ is $217.60, compared to a current price of $44.61 — trading 79.5% below its estimated fair value. The current EV-to-FCF is 10.66 and 53.4% below the Medical Devices & Instruments industry median of 22.90. Inspire Medical Systems' overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Inspire Medical Systems (INSP), the current EV-to-FCF is 10.66 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (INSP) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of $44.61 is trading 79.5% below its estimated GF Value™ of $217.60.
GuruFocus considers Inspire Medical Systems to be Possible Value Trap.
Key valuation signals for INSP:
EV-to-FCF: 10.66
GF Value™: $217.60 vs. price of $44.61 (79.5% below fair value)
Industry Position: 53.4% below the Medical Devices & Instruments median (#82 of 418)
No single metric tells the full story. See the INSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
54GF Score
Get the complete analysis for INSP
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INSP has been successfully added to your 
